Transforming growth factor-beta in human cutaneous leishmaniasis.

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

1983 • 1,918 citations

Deactivation of macrophages by transforming growth factor-β

1988 • 876 citations

The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania major

1994 • 687 citations

Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions

1989 • 592 citations

Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

1990 • 507 citations

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

1987 • 497 citations

Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

1990 • 453 citations

Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape Mechanism

1992 • 439 citations

Mucosal leishmaniasis (“spundia” Escomel, 1911)

1986 • 374 citations

Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

1991 • 309 citations

Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

1988 • 298 citations

Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.

1989 • 256 citations

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.

1993 • 217 citations

Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.

1993 • 208 citations

Diffuse cutaneous leishmaniasis in Ethiopia I. The clinical and histological features of the disease

1969 • 173 citations

Selection of a Skin Test Antigen for American Visceral Leishmaniasis

1986 • 169 citations

Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis.

1990 • 168 citations

Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis

1994 • 166 citations

Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

1988 • 155 citations

Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.

1991 • 147 citations

Evaluation of the Micro Enzyme-Linked Immunosorbent Assay (ELISA) for Antibodies in American Visceral Leishmaniasis: Antigen Selection for Detection of Infection-Specific Responses *

1986 • 136 citations

Leishmania major interferes with antigen presentation by infected macrophages.

1993 • 124 citations

Tumor Necrosis Factor (Cachectin) in Human Visceral Leishmaniasis

1991 • 113 citations

Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.

1994 • 111 citations

Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.

1984 • 101 citations

POLAR AND SUBPOLAR DIFFUSE CUTANEOUS LEISHMANIASIS IN BRAZIL: CLINICAL AND IMMUNOPATHOLOGIC ASPECTS

1995 • 98 citations

Immunologic responsiveness in American cutaneous leishmaniasis lesions.

1990 • 76 citations

Cytotoxicity in human mucosal and cutaneous leishmaniasis

1995 • 61 citations

Phagocytosis of Leishmania enhances macrophage activation by IFN-gamma and lipopolysaccharide.

1991 • 56 citations

Transforming growth factor-beta in tegumentary leishmaniasis.

1994 • 23 citations